This program is a subset of the Drug Diversion (DD), Poison Center (PC), Opioid Treatment Program (OTP) and Survey of Key Informants’ Patients (SKIP) program.
Cases are defined as follows:
- DD: diversion cases identified by regulatory agencies which include medical boards, pharmacy boards, dental boards, and nursing boards. These agencies specialize in the detection, treatment, and sanctioning of impaired health care workers who are involved in the diversion of prescription pharmaceuticals.
- PC: intentional exposures with documentation in the case notes that the individual exposed is a health care worker.
- OTP: self-reported use of a prescription or illicit opioid to get high in the past 30 days by respondents who self-identify as health care workers on the questionnaire.
- SKIP: self-reported use of a prescription or illicit opioid to get high in the past 30 days by respondents who self-identify as health care workers on the questionnaire.
- Richard C. Dart, M.D., Ph.D. (Primary Principal Investigator)
Rocky Mountain Poison and Drug Center
A division of Denver Health and Hospital Authority
- Principal Investigators of all signal detection programs (DD, OTP, SKIP)